John M. Leonard
President and CEO at Intellia Therapeutics Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Intellia Therapeutics Inc., 3 years.
Intellia Therapeutics Inc.
Director · President and CEO
IQVIA Holdings Inc.
Director
Chief executive roles
Intellia Therapeutics Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 23, 2026 | IQVIA Holdings Inc. | Grant or award | +1,571 | — | — |
| Mar 1, 2026 | Intellia Therapeutics Inc. | Grant or award | +156,400 | — | — |
| Jan 5, 2026 | Intellia Therapeutics Inc. | Open-market sale | −34,146 | $9.21 | $314,485 |
| Dec 12, 2025 | Intellia Therapeutics Inc. | Option exercise | +8,557 | $6.83 | $58,444 |
| Dec 11, 2025 | Intellia Therapeutics Inc. | Option exercise | +49,959 | $6.83 | $341,220 |
| Dec 11, 2025 | Intellia Therapeutics Inc. | Open-market sale | −49,959 | $9.49 | $474,111 |
| Dec 11, 2025 | Intellia Therapeutics Inc. | Open-market sale | −32,832 | $9.47 | $310,919 |
| Dec 11, 2025 | Intellia Therapeutics Inc. | Open-market sale | −5,355 | $9.59 | $51,354 |
| Apr 24, 2025 | IQVIA Holdings Inc. | Grant or award | +1,592 | — | — |
| Mar 1, 2025 | Intellia Therapeutics Inc. | Grant or award | +136,000 | — | — |
| Jan 3, 2025 | Intellia Therapeutics Inc. | Open-market sale | −26,807 | $12.18 | $326,509 |
| Jan 1, 2025 | Intellia Therapeutics Inc. | Option exercise | +7,850 | — | — |
| May 7, 2024 | IQVIA Holdings Inc. | Grant or award | +1,047 | — | — |
| Mar 1, 2024 | Intellia Therapeutics Inc. | Grant or award | +113,586 | — | — |
| Jan 3, 2024 | Intellia Therapeutics Inc. | Open-market sale | −19,223 | $29.46 | $566,310 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.